首页|巨噬细胞上髓系细胞触发受体-1/2在炎症性肠病中的作用研究进展

巨噬细胞上髓系细胞触发受体-1/2在炎症性肠病中的作用研究进展

扫码查看
炎症性肠病(inflammatory bowel disease,IBD)是以克罗恩病(Crohn's disease,CD)和溃疡性结肠炎(ulcerative colitis,UC)为代表的慢性肠道炎症性疾病,机制涉及遗传易感性以及环境与微生物群间相互作用削弱肠道屏障导致免疫激活等多种途径.近年来,巨噬细胞上表达的TREMs(triggering receptors expressed on myeloid cells),即髓系细胞触发受体,被发现在固有免疫和适应性免疫中发挥重要作用,并与IBD的发生发展密切相关.本文将着重对TREM-1/2(TREM-1和TREM-2)的结构、配体和作用,其在巨噬细胞上参与IBD与伴发精神障碍的机制研究进行概述,旨在为IBD的预防和治疗提供理论支持.
Research Progress on the Roles of TREM-1/2 on Macrophages in Inflammatory Bowel Disease
Inflammatory bowel disease(IBD)is a chronic intestinal inflammatory disease repre-sented by Crohn's disease(CD)and ulcerative colitis(UC).Mechanisms underlying its onset and development involve genetic susceptibility,as well as multiple pathways such as the environmen-tal and microbial interactions that weaken the intestinal barrier and lead to immune activation.Recent research has indicated that triggering receptors expressed on myeloid cells(TREMs)ex-pressed on macrophages play critical roles in both innate and adaptive immune responses,closely associated with the occurrence and development of IBD.This article reviews the structures,lig-ands,and functions of TREM-1/2(TREM-1 and TREM-2),as well as mechanisms underlying the involvement of TREM-1/2 in IBD and the accompanying mental disorders,aiming to provide theoretical support for the prevention and treatment of IBD.

inflammatory bowel diseasemacrophageTREM-1TREM-2

周子鸣、张咏梅

展开 >

徐州医科大学江苏省麻醉学重点实验室,徐州 221004

徐州医科大学江苏省麻醉与镇痛应用技术重点实验室,徐州 221004

徐州医科大学国家药品监督管理局麻醉精神药物研究与评价重点实验室,徐州 221004

炎症性肠病 巨噬细胞 TREM-1 TREM-2

科技创新2030重大项目国家自然科学基金国家自然科学基金江苏省研究生科研创新计划

2021ZD02031008227125782071228KYCX23_2957

2024

生理科学进展
中国生理学会,北京大学

生理科学进展

CSTPCD北大核心
影响因子:0.635
ISSN:0559-7765
年,卷(期):2024.55(2)
  • 60